barium has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C; Ning, C; Piao, J; Qi, S; Xiao, C; Yang, F; Yu, P; Zhai, J; Zhan, L; Zhou, Z | 1 |
| Lee, H; Murugan, C; Park, S | 1 |
2 other study(ies) available for barium and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Internal Wireless Electrical Stimulation from Piezoelectric Barium Titanate Nanoparticles as a New Strategy for the Treatment of Triple-Negative Breast Cancer.
Topics: Animals; Barium; Cell Line, Tumor; Cell Movement; Cell Proliferation; Electric Stimulation; Humans; Mice; Nanoparticles; Triple Negative Breast Neoplasms | 2022 |
Tumor-targeted molybdenum disulfide@barium titanate core-shell nanomedicine for dual photothermal and chemotherapy of triple-negative breast cancer cells.
Topics: Barium; Humans; Molybdenum; Nanomedicine; Phototherapy; Triple Negative Breast Neoplasms | 2023 |